New application of virus inhibitor composition in inhibition and treatment of new crown
The invention belongs to the technical field of medicines, and particularly relates to a novel application of a virus inhibitor composition in inhibition and treatment of new crowns, including an application in preparation of a cysteine protease Mpro inhibitor and an application in preparation of a...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Patent |
| Sprache: | chi ; eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | ZHANG KAI JIN HONG WANG LINGYOU |
| description | The invention belongs to the technical field of medicines, and particularly relates to a novel application of a virus inhibitor composition in inhibition and treatment of new crowns, including an application in preparation of a cysteine protease Mpro inhibitor and an application in preparation of a medicine for preventing or treating coronavirus infection diseases. As a 3CL protease (3-cymotrypsin-likeprotein, 3CLpro) inhibitor for resisting SAR-CoV-2 infection (COVID-19), the result of emergency voluntary use which has been completed at present shows that the safety and tolerance of a subject after the subject takes the medicine are good, and serious adverse events or adverse events causing drug withdrawal are not observed, so that the application of the 3-cymotrypsin-likeprotein inhibitor for treating the SAR-CoV-2 infection (COVID-19) has the advantages that the safety and tolerance of the subject after the subject takes the medicine are good, and the application range of the 3-cymotrypsin-likeprotein inhi |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN116019851A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN116019851A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN116019851A3</originalsourceid><addsrcrecordid>eNrjZAj3Sy1XSCwoyMlMTizJzM9TyE9TKMssKi1WyMzLyEzKLMkvUkjOzy3IL84ES2fmwSRAvMS8FIWSotTEktzUvBKQ1jygaclF-eV5PAysaYk5xam8UJqbQdHNNcTZQze1ID8-tbggMTk1L7Uk3tnP0NDMwNDSwtTQ0ZgYNQCaXDpZ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>New application of virus inhibitor composition in inhibition and treatment of new crown</title><source>esp@cenet</source><creator>ZHANG KAI ; JIN HONG ; WANG LINGYOU</creator><creatorcontrib>ZHANG KAI ; JIN HONG ; WANG LINGYOU</creatorcontrib><description>The invention belongs to the technical field of medicines, and particularly relates to a novel application of a virus inhibitor composition in inhibition and treatment of new crowns, including an application in preparation of a cysteine protease Mpro inhibitor and an application in preparation of a medicine for preventing or treating coronavirus infection diseases. As a 3CL protease (3-cymotrypsin-likeprotein, 3CLpro) inhibitor for resisting SAR-CoV-2 infection (COVID-19), the result of emergency voluntary use which has been completed at present shows that the safety and tolerance of a subject after the subject takes the medicine are good, and serious adverse events or adverse events causing drug withdrawal are not observed, so that the application of the 3-cymotrypsin-likeprotein inhibitor for treating the SAR-CoV-2 infection (COVID-19) has the advantages that the safety and tolerance of the subject after the subject takes the medicine are good, and the application range of the 3-cymotrypsin-likeprotein inhi</description><language>chi ; eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230428&DB=EPODOC&CC=CN&NR=116019851A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,778,883,25547,76298</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230428&DB=EPODOC&CC=CN&NR=116019851A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>ZHANG KAI</creatorcontrib><creatorcontrib>JIN HONG</creatorcontrib><creatorcontrib>WANG LINGYOU</creatorcontrib><title>New application of virus inhibitor composition in inhibition and treatment of new crown</title><description>The invention belongs to the technical field of medicines, and particularly relates to a novel application of a virus inhibitor composition in inhibition and treatment of new crowns, including an application in preparation of a cysteine protease Mpro inhibitor and an application in preparation of a medicine for preventing or treating coronavirus infection diseases. As a 3CL protease (3-cymotrypsin-likeprotein, 3CLpro) inhibitor for resisting SAR-CoV-2 infection (COVID-19), the result of emergency voluntary use which has been completed at present shows that the safety and tolerance of a subject after the subject takes the medicine are good, and serious adverse events or adverse events causing drug withdrawal are not observed, so that the application of the 3-cymotrypsin-likeprotein inhibitor for treating the SAR-CoV-2 infection (COVID-19) has the advantages that the safety and tolerance of the subject after the subject takes the medicine are good, and the application range of the 3-cymotrypsin-likeprotein inhi</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZAj3Sy1XSCwoyMlMTizJzM9TyE9TKMssKi1WyMzLyEzKLMkvUkjOzy3IL84ES2fmwSRAvMS8FIWSotTEktzUvBKQ1jygaclF-eV5PAysaYk5xam8UJqbQdHNNcTZQze1ID8-tbggMTk1L7Uk3tnP0NDMwNDSwtTQ0ZgYNQCaXDpZ</recordid><startdate>20230428</startdate><enddate>20230428</enddate><creator>ZHANG KAI</creator><creator>JIN HONG</creator><creator>WANG LINGYOU</creator><scope>EVB</scope></search><sort><creationdate>20230428</creationdate><title>New application of virus inhibitor composition in inhibition and treatment of new crown</title><author>ZHANG KAI ; JIN HONG ; WANG LINGYOU</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN116019851A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2023</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>ZHANG KAI</creatorcontrib><creatorcontrib>JIN HONG</creatorcontrib><creatorcontrib>WANG LINGYOU</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>ZHANG KAI</au><au>JIN HONG</au><au>WANG LINGYOU</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>New application of virus inhibitor composition in inhibition and treatment of new crown</title><date>2023-04-28</date><risdate>2023</risdate><abstract>The invention belongs to the technical field of medicines, and particularly relates to a novel application of a virus inhibitor composition in inhibition and treatment of new crowns, including an application in preparation of a cysteine protease Mpro inhibitor and an application in preparation of a medicine for preventing or treating coronavirus infection diseases. As a 3CL protease (3-cymotrypsin-likeprotein, 3CLpro) inhibitor for resisting SAR-CoV-2 infection (COVID-19), the result of emergency voluntary use which has been completed at present shows that the safety and tolerance of a subject after the subject takes the medicine are good, and serious adverse events or adverse events causing drug withdrawal are not observed, so that the application of the 3-cymotrypsin-likeprotein inhibitor for treating the SAR-CoV-2 infection (COVID-19) has the advantages that the safety and tolerance of the subject after the subject takes the medicine are good, and the application range of the 3-cymotrypsin-likeprotein inhi</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | chi ; eng |
| recordid | cdi_epo_espacenet_CN116019851A |
| source | esp@cenet |
| subjects | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | New application of virus inhibitor composition in inhibition and treatment of new crown |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T06%3A52%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=ZHANG%20KAI&rft.date=2023-04-28&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN116019851A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |